Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ceribell (CBLL) Change in Account Payables (2023 - 2026)

Ceribell posted quarterly Change in Account Payables of -$857000.0 for Q1 2026, down 348.41% year-on-year from $345000.0 in Q1 2025, and down 245.5% on a QoQ basis from $589000.0 in Q4 2025.

Ceribell (CBLL) has 4 years of Change in Account Payables data on file, last reported at -$857000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 348.41% year-over-year to -$857000.0; the trailing twelve-month figure through Mar 2026 stood at $543000.0 (up 86.6% YoY), and the FY2025 full-year result was $1.7 million, up 598.0% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$857000.0, down from $589000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.0 million in Q2 2025 and bottomed at -$903000.0 in Q4 2024.
  • The 4-year median for Change in Account Payables is $151000.0 (2024), against an average of $59900.0.
  • The widest annual swing landed in 2025, when Change in Account Payables soared 50900.0%; it then slumped 348.41% in 2026.
  • A 4-year view of Change in Account Payables shows it stood at -$539000.0 in 2023, then plunged by 67.53% to -$903000.0 in 2024, then surged by 165.23% to $589000.0 in 2025, then tumbled by 245.5% to -$857000.0 in 2026.
  • The last three Change in Account Payables figures came in at -$857000.0 (Q1 2026), $589000.0 (Q4 2025), and -$205000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -198.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 221.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 56.90 Mn
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn -857,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -857,000.00
Mar 31, 2026 -857,000.00
Dec 31, 2025 589,000.00
Dec 31, 2025 589,000.00
Sep 30, 2025 -205,000.00
Sep 30, 2025 -205,000.00
Jun 30, 2025 1.02 Mn
Jun 30, 2025 1.02 Mn
Mar 31, 2025 345,000.00
Mar 31, 2025 345,000.00
Dec 31, 2024 -903,000.00
Dec 31, 2024 -903,000.00
Sep 30, 2024 851,000.00
Sep 30, 2024 851,000.00
Jun 30, 2024 -2,000.00
Jun 30, 2024 -2,000.00
Mar 31, 2024 304,000.00
Mar 31, 2024 304,000.00
Dec 31, 2023 -539,000.00
Dec 31, 2023 -539,000.00